MX2020003551A - Metodos de tratamiento de dolor agudo o cronico. - Google Patents

Metodos de tratamiento de dolor agudo o cronico.

Info

Publication number
MX2020003551A
MX2020003551A MX2020003551A MX2020003551A MX2020003551A MX 2020003551 A MX2020003551 A MX 2020003551A MX 2020003551 A MX2020003551 A MX 2020003551A MX 2020003551 A MX2020003551 A MX 2020003551A MX 2020003551 A MX2020003551 A MX 2020003551A
Authority
MX
Mexico
Prior art keywords
methods
chronic pain
treating acute
treating
provides methods
Prior art date
Application number
MX2020003551A
Other languages
English (en)
Inventor
David Roberson
Ajay Yekkirala
Michio Painter
Original Assignee
Blue Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blue Therapeutics Inc filed Critical Blue Therapeutics Inc
Publication of MX2020003551A publication Critical patent/MX2020003551A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona métodos para el tratamiento del dolor crónico y agudo. Por ejemplo, la invención proporciona métodos para el tratamiento del dolor neuropático e inflamatorio.
MX2020003551A 2017-10-06 2018-10-08 Metodos de tratamiento de dolor agudo o cronico. MX2020003551A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762569315P 2017-10-06 2017-10-06
PCT/US2018/054884 WO2019071264A1 (en) 2017-10-06 2018-10-08 Methods of treating acute or chronic pain

Publications (1)

Publication Number Publication Date
MX2020003551A true MX2020003551A (es) 2020-12-10

Family

ID=65995315

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003551A MX2020003551A (es) 2017-10-06 2018-10-08 Metodos de tratamiento de dolor agudo o cronico.

Country Status (9)

Country Link
US (1) US11464772B2 (es)
EP (1) EP3691644A4 (es)
JP (1) JP2020536891A (es)
CN (1) CN111757738A (es)
AU (1) AU2018345909A1 (es)
CA (1) CA3076233A1 (es)
IL (1) IL273500A (es)
MX (1) MX2020003551A (es)
WO (1) WO2019071264A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022155332A1 (en) * 2021-01-13 2022-07-21 Blue Therapeutics, Inc. Methods of treating irritable bowel syndrome

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
JP2006131545A (ja) * 2004-11-05 2006-05-25 Japan Science & Technology Agency 神経因性疼痛治療剤
AR064001A1 (es) * 2006-11-30 2009-03-04 Cenerx Bio Pharma Inc Esteres de dialquilaminoalquilo de pivagabina como medicamentos para el tratamiento de trastornos del sistema nervioso central, metodos para su preparacion y composiciones farmaceuticas que los comprenden.
US8609682B2 (en) 2008-07-11 2013-12-17 Regents Of The University Of Minnesota Analgesic agents
WO2010083384A2 (en) * 2009-01-16 2010-07-22 Virginia Commonwealth University Non-peptidyl, potent, and selective mu opioid receptor antagonists
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
WO2014091297A1 (en) * 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
EP2931724B1 (en) * 2012-12-14 2017-01-25 Purdue Pharma LP Pyridonemorphinan analogs and biological activity on opioid receptors
WO2016138142A1 (en) 2015-02-24 2016-09-01 Regents Of The University Of Minnesota Therapeutic compounds

Also Published As

Publication number Publication date
AU2018345909A1 (en) 2020-04-09
WO2019071264A1 (en) 2019-04-11
EP3691644A4 (en) 2021-06-30
US11464772B2 (en) 2022-10-11
CN111757738A (zh) 2020-10-09
JP2020536891A (ja) 2020-12-17
IL273500A (en) 2020-05-31
US20200289500A1 (en) 2020-09-17
CA3076233A1 (en) 2019-04-11
EP3691644A1 (en) 2020-08-12

Similar Documents

Publication Publication Date Title
ZA202107931B (en) Anti-tau antibodies and methods of use
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
MX2020005772A (es) Composiciones que comprenden cepas bacterianas.
MX2024000300A (es) Anticuerpos antitau y metodos de uso.
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
MX2018006398A (es) Composiciones que comprenden cepas bacterianas.
MX2017016525A (es) Composiciones que comprenden cepas bacterianas.
MX2019001471A (es) Anticuerpos anti-siglec-7 para el tratamiento del cancer.
MX2019006330A (es) Anticuerpos anti-tau y metodos de uso.
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
MX2021006326A (es) Inhibidores de pcna.
MX2018016057A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
MX2022007955A (es) Regimenes de dosificacion de erdafitinib.
PH12017501864A1 (en) Compositions and methods for treating autism
MX2019006552A (es) Terapia génica para mucopolisacaridosis de tipo i.
PH12018501455A1 (en) Therapeutic compostions and methods for treating hepatitis b
MX2017016114A (es) Metodos para tratar o prevenir una proteopatia.
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
ZA202211980B (en) Methods and treatment of trauma
EP4480577A3 (en) Structured elements and methods of use
MX2020003587A (es) Metodo de tratamiento de una lamina de metal y la lamina de metal tratada con este metodo.
MX2020003633A (es) Metodo de tratamiento de una lamina de metal y la lamina de metal tratada con este metodo.
HK1250145A1 (zh) 治疗多发性骨髓瘤的组合物和方法